24
Jun
2025

BrightGene Bio-Medical Technology Co., Ltd.

Exhibitor at CPHI & PMEC China 2025 stand W2B01, Pharma Ingredients
About Us

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. 

We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis....

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
View company profile
Contact info
  • +86 512-62551764
  • Website
  • Room C26-C27, Suzhou biological nano-technology park, No.218 Xinghu Street, 215123, Suzhou, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2025
  • 24 Jun 2025 - 26 Jun 2025
  • Shanghai New International Expo Center
  • Visit us at stand W2B01, Pharma Ingredients

Products Featured at CPHI & PMEC China 2025

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate
  • SGB

    Product SGB

    • Status: Commercial • Usage:  For Saxagliptin
  • SGA

    Product SGA

    • Status: Commercial • Usage:  For Saxagliptin
  • Ascomycin

    Product Ascomycin

    • Status: DMF No.: 029433 • Usage: Oncology
  • Pneumocandin B0

    Product Pneumocandin B0

    • Status: DMF Ready • Usage: For Caspofungin
  • Echinocandin B0

    Product Echinocandin B0

    • Status: DMF Ready • Usage: For Anidulafungin
  • POB

    Product POB

    • Status: DMF Ready • Usage: For Posaconazole
  • POA

    Product POA

    • Status: DMF Ready • Usage: For Posaconazole
  • MFA

    Product MFA

    • Status: DMF No.:030028 • Usage: For Micafungin
  • ET1

    Product ET1

    • Status: DMF No.: 026257 • Usage: For Entecavir
  • FSC

    Product FSC

    • Status: DMF No.: 028552 • Usage: For Fondaparinux Sodium
  • Dydrogesterone

    Product Dydrogesterone

    • Status: Pilot • Patent Expiration: Off-patent • Usage: Progestogens
  • Oritavancin

    Product Oritavancin

    • Status: Pre-validation • Patent Expiration: Off-patent • Usage: Anti-infection
  • Pimecrolimus

    Product Pimecrolimus

    • Status: DMF No.: 030090 • Patent Expiration: Off-patent • Usage: Immunosuppressant
  • Everolimus（without BHT）

    Product Everolimus（without BHT）

    • Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology
  • Midostaurin

    Product Midostaurin

    • Status: Validated • Patent Expiration: Off-patent • Usage: Oncology
  • Fondaparinux Sodium

    Product Fondaparinux Sodium

    • Status: DMF No. :030767 • Patent Expiration: Off-patent • Usage:Anticoagulant
  • Anidulafungin

    Product Anidulafungin

    Status:
    DMF No.: 032010                                              
    ASMF Approved
    Patent Expiration: Off-patentUsage: Antifungal
  • Argatroban Monohydrate

    Product Argatroban Monohydrate

    • Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant
  • Caspofungin Acetate

    Product Caspofungin Acetate

    • Status: ASMF Approved & DMF No.:034091 • Patent Expiration:Off-patent • Usage:Antifungal
  • Entecavir monohydrate

    Product Entecavir monohydrate

    Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes entecavir monohydrate. It belongs to anti-viral category. Contact us for more information. • Status: DMF No.:031949 • Patent Expiration: Off-patent • Usage:AntiHBV
  • Eribulin Mesilate

    Product Eribulin Mesilate

    • Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology
  • Everolimus(2.0% BHT)

    Product Everolimus(2.0% BHT)

    • Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology
  • Fidaxomicin

    Product Fidaxomicin

    • Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection
  • Fondaparinux Sodium

    Product Fondaparinux Sodium

    Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information.
  • Micafungin Sodium

    Product Micafungin Sodium

    • Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal
  • Posaconazole Amorphous

    Product Posaconazole Amorphous

    • Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal
  • Telavancin Hydrochloride

    Product Telavancin Hydrochloride

    • Status: Pilot • Patent Expiration: US: 2027.1.1 • Usage: Anti-infection
  • Trabectedin

    Product Trabectedin

    • Status: Validated • Patent Expiration: ODE：2022.10.23；NCE：2020.10.23 • Usage: Oncology
  • Alvimopan

    Product Alvimopan

    • Status: Pre-validation • Patent Expiration: US：2022.11 • Usage: Intestinal Ostruction
  • Posaconazole(Form Ⅰ)

    Product Posaconazole(Form Ⅰ)

    • Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal
  • Posaconazole(Form Ⅲ)

    Product Posaconazole(Form Ⅲ)

    • Status: DMF No.:030886 • Patent Expiration: Off-patent • Usage: Antifungal
  • Sugammadex Sodium

    Product Sugammadex Sodium

    • Status: DMF No. :033904 • Patent Expiration: US：2021.01.27； CN：2020.11.23 • Usage:Selective relaxant binding agent 
  • Tenofovir alafenamide,TAF

    Product Tenofovir alafenamide,TAF

    • Status: Validated • Patent Expiration: CN：2021.7；US：2032.8 • Usage: AntiHBV
  • Dalbavancin

    Product Dalbavancin

    • Status: Validated, DMF will be ready to file at Q1,2021 • Patent Expiration: GAIN：2024.5.23 • Usage: Anti-infection
  • Oseltamivir phosphate

    Product Oseltamivir phosphate

    • Status: Validated and DMF ready • Patent Expiration: Off-patent • Usage: Anti-infection
  • Doramectin

    Product Doramectin

    • Status: Commercial • Patent Expiration: Off-patent • Usage: Veterinary
  • Eldecalcitol

    Product Eldecalcitol

    • Status: Pre-validation • Patent Expiration: Off-patent • Usage: Osteoporosis
  • Emodepside

    Product Emodepside

    • Status: Pilot • Patent Expiration: Off-patent • Usage: Veterinary
  • Ferric carboxymaltose

    Product Ferric carboxymaltose

    • Status: Pre-validation, PV will be done in Oct  • Patent Expiration: US：2027.03.04; • Usage: Iron Supplement
  • Ferric citrate hydrate

    Product Ferric citrate hydrate

    • Status: Pilot • Patent Expiration: Off-patent • Usage: Iron Supplement
  • Ferric Pyrophosphate Citrate

    Product Ferric Pyrophosphate Citrate

    • Status: Pilot • Patent Expiration: US：2029.4.18 • Usage: Iron Supplement
  • Ferumoxytol

    Product Ferumoxytol

    • Status: Pilot • Patent Expiration: Off-patent • Usage: Iron Supplement
  • Selamectin

    Product Selamectin

    • Status: Commercial • Patent Expiration: Off-patent • Usage: Veterinary
  • Spinosad

    Product Spinosad

    • Status: Pre-validation • Patent Expiration: Off-patent • Usage: Pediculicide / Veterinary
  • Calicheamicin

    Product Calicheamicin

    • Status: Pilot • Usage:  Antibody-drug Conjugate

Recently Visited